首页> 外文期刊>BMC Nephrology >Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition
【24h】

Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition

机译:透析患者的生存率在以糖尿病为原发性肾脏疾病的患者和合并糖尿病的糖尿病患者中没有差异

获取原文
           

摘要

Background On dialysis, survival among patients with diabetes mellitus is inferior to survival of non-diabetic patients. We hypothesized that patients with diabetes as primary renal disease have worse survival compared to patients with diabetes as a co-morbid condition and aimed to compare all-cause mortality between these patient groups. Methods Data were collected from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD), a multicenter, prospective cohort study in which new patients with end stage renal disease (ESRD) were monitored until transplantation or death. Patients with diabetes as primary cause of ESRD were compared with patients with diabetes as co-morbid condition and both of these patient groups were compared to patients without diabetes. Analysis was performed using Kaplan-Meier and Cox regression. Results Fifteen % of the patients had diabetic nephropathy as primary renal disease (N = 281); 6% had diabetes as co-morbid condition (N = 107) and 79% had no diabetes (N = 1465). During follow-up 42% of patients (N = 787) died. Compared to non-diabetic patients, mortality risk was increased for both patients with diabetes as primary renal disease HR: 1.9 (95% CI 1.6, 2.3) and for patients with diabetes as co-morbid condition HR: 1.7 (95% CI 1.3, 2.2). Mortality was not significantly higher in patients with diabetes as primary renal disease compared to patients with diabetes as co-morbid condition (HR 1.06; 95% CI 0.79, 1.43). Conclusions This study in patients with ESRD showed no survival difference between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Both conditions were associated with increased mortality risk compared to non-diabetic patients.
机译:背景技术在透析方面,糖尿病患者的生存率低于非糖尿病患者的生存率。我们假设患有糖尿病的原发性肾病患者比患有合并症的糖尿病患者的生存期更差,旨在比较这些患者组之间的全因死亡率。方法:数据收集自荷兰透析充分性合作研究(NECOSAD),这是一项多中心,前瞻性队列研究,在该研究中,监测新的终末期肾病患者(ESRD)直至移植或死亡。将糖尿病患者作为ESRD的主要病因,将糖尿病患者与合并症患者进行比较,并将这两个患者组与没有糖尿病的患者进行比较。使用Kaplan-Meier和Cox回归进行分析。结果15%的糖尿病肾病为原发性肾病(N = 281); 6%为合并症患者(N = 107),无糖尿病(N = 1465)为79%。在随访期间,有42%的患者(N = 787)死亡。与非糖尿病患者相比,患有糖尿病的原发性肾病患者HR的危险性均增加:1.9(95%CI 1.6,2.3)和患有合并症的糖尿病患者HR:1.7(95%CI 1.3, 2.2)。与患有合并症的糖尿病患者相比,作为原发性肾脏疾病的糖尿病患者的死亡率没有显着更高(HR 1.06; 95%CI 0.79,1.43)。结论这项针对ESRD患者的研究表明,糖尿病作为原发性肾脏疾病的患者与糖尿病合并症的患者的生存率无差异。与非糖尿病患者相比,这两种情况均增加了死亡风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号